EN PL
ARTYKUŁ REDAKCYJNY
Vaccinations in autoimmune inflammatory rheumatic diseases
 
Więcej
Ukryj
 
Data publikacji online: 30-12-2016
 
 
Reumatologia 2016;54(6):275-277
 
 
REFERENCJE (8)
1.
Heijstek MW, Ott de Bruin LM, Bijl M, et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis 2011; 70: 1704-1712.
 
2.
Szczepienie dzieci chorych na autoimmunologiczne choroby – Zalecenia European League Against Rhematism (EULAR) http://www.mp.pl/szczepienia/a....
 
3.
Groot N, Heijstek MW, Wulffraat NM. Vaccinations in paediatric rheumatology: an update on current developments. Curr Rheumatol Rep 2015; 17: 46.
 
4.
Schipper K, Bakker M, De Wit M, et al. Strategies for disseminating recommendations or guidelines to patients: a systematic review. Implement Sci 2016; 11: 82.
 
5.
Barbosa CM, Terreri MT, Rosário PO, et al. Immune response and tolerability of varicella vaccine in children and adolescents with systemic lupus erythematosus previously exposed to varicella-zoster virus. Clin Exp Rheumatol 2012; 30: 791-798.
 
6.
Heijstek MW, Kamphuis S, Armbrust W, et al. Effects of the live attenuated measles-mumps-rubella booster vaccination on disease activity in patients with juvenile idiopathic arthritis: a randomized trial. JAMA 2013; 309: 2449-2456.
 
7.
Martión-Torres F, Bernatowska E, Shcherbina A, et al. The immunogenicity of a serogroup B meningococcal vaccine (4CMenB) in children with complement deficiency, asplenia or splenic dysfunction. Abstract book 20th International Pathogenic Neisseria Conference, 4th–9th September 2016. Manchester, United Kingdomhttp://www.ipnc2016.org/IPNC2016 AbstractBook.pdf abstract 154, p. 244.
 
8.
Naleway AL, Crane B, Smith N, et al. Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination. Vaccine Safety Datalink, 2008-2011. Vaccine 2016; 34: 167-171.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top